Loading...
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial.
Horwitz, S O'Connor, O Pro, B Illidge, Timothy M Fanale, M Advani, R Bartlett, N Christensen, J Morschhauser, F Domingo-Domenech, E
Horwitz, S
O'Connor, O
Pro, B
Illidge, Timothy M
Fanale, M
Advani, R
Bartlett, N
Christensen, J
Morschhauser, F
Domingo-Domenech, E
Citations
Altmetric:
Abstract
Authors
Horwitz, S
O'Connor, O
Pro, B
Illidge, Timothy M
Fanale, M
Advani, R
Bartlett, N
Christensen, J
Morschhauser, F
Domingo-Domenech, E
Rossi, G
Kim, W
Feldman, T
Lennard, A
Belada, D
Illes, A
Tobinai, K
Tsukasaki, K
Yeh, S
Shustov, A
Huttmann, A
Savage, K
Yuen, S
Iyer, S
Zinzani, P
Hua, Z
Little, M
Rao, S
Woolery, J
Manley, T
Trumper, L
Aboulafia, D
Alpdogan, O
Ando, K
Arcaini, L
Baldini, L
Bellam, N
Bartlett, N
Yehuda, DB
Benedetti, F
Borchman, P
Bordessoule, D
Brice, P
Briones, J
Caballero, D
Carella, A
Chang, H
Cheong, J
Cho, S
Choi, I
Choquet, S
Colita, A
Congui, A
D'amore, F
Dang, N
Davison, K
De, Guibert S
Brown, P
Delwail, V
Demeter, J
di Raimondo, F
Do, Y
Domingo, E
Douvas, M
Dreyling, M
Ernst, T
Fay, K
Ferrero, S
Flinn, I
Forero-Torres, A
Fox, C
Friedberg, J
Fukuhara, N
Garcia-Marco, J
Cruz, J
Codina, J
Gressin, R
Grigg, A
Gurion, R
Haioun, C
Hajek, R
Hanel, M
Hatake, K
Hensen, R
Horowitz, N
Huttmann, A
Ishizawa, K
Islas-Ohlmayer, M
Jacobsen, E
Janakiram, M
Jurczak, W
Kaminski, M
Kato, K
Kirgner, I
Kuo, C
Lazaroiu, M
Le, Du, K
Lee, J
Legouill, S
Larosee, P
Levi, I
Link, B
Maisonneuve, H
Maruyama, D
Mayer, J
McCarty, J
Mckay, P
Minami, Y
Mocikova, H
Morra, E
Munoz, J
Nagai, H
O'Connor, O
Opat, S
Pettengell, R
Pezzutto, A
Pfreundschuh, M
Pluta, A
Porcu, P
Quach, H
Rambaldi, A
Renwick, W
Reyes, R
Izquierdo, A
Ruan, J
Rusconi, C
Salles, G
Santoro, A
Sarriera, J
Savage, K
Shibayama, H
Suh, C
Sureda, A
Tanimoto, M
Taniwaki, M
Tilly, H
Trneny, M
Trumper, L
Tsukamoto, N
Vitolo, U
Walewski, J
Weidmann, E
Wilhelm, M
Witzens-Harig, M
Yacoub, A
Yamamoto, K
Yoon, S
Yun, H
Zain, J
Zinzan, P
O'Connor, O
Pro, B
Illidge, Timothy M
Fanale, M
Advani, R
Bartlett, N
Christensen, J
Morschhauser, F
Domingo-Domenech, E
Rossi, G
Kim, W
Feldman, T
Lennard, A
Belada, D
Illes, A
Tobinai, K
Tsukasaki, K
Yeh, S
Shustov, A
Huttmann, A
Savage, K
Yuen, S
Iyer, S
Zinzani, P
Hua, Z
Little, M
Rao, S
Woolery, J
Manley, T
Trumper, L
Aboulafia, D
Alpdogan, O
Ando, K
Arcaini, L
Baldini, L
Bellam, N
Bartlett, N
Yehuda, DB
Benedetti, F
Borchman, P
Bordessoule, D
Brice, P
Briones, J
Caballero, D
Carella, A
Chang, H
Cheong, J
Cho, S
Choi, I
Choquet, S
Colita, A
Congui, A
D'amore, F
Dang, N
Davison, K
De, Guibert S
Brown, P
Delwail, V
Demeter, J
di Raimondo, F
Do, Y
Domingo, E
Douvas, M
Dreyling, M
Ernst, T
Fay, K
Ferrero, S
Flinn, I
Forero-Torres, A
Fox, C
Friedberg, J
Fukuhara, N
Garcia-Marco, J
Cruz, J
Codina, J
Gressin, R
Grigg, A
Gurion, R
Haioun, C
Hajek, R
Hanel, M
Hatake, K
Hensen, R
Horowitz, N
Huttmann, A
Ishizawa, K
Islas-Ohlmayer, M
Jacobsen, E
Janakiram, M
Jurczak, W
Kaminski, M
Kato, K
Kirgner, I
Kuo, C
Lazaroiu, M
Le, Du, K
Lee, J
Legouill, S
Larosee, P
Levi, I
Link, B
Maisonneuve, H
Maruyama, D
Mayer, J
McCarty, J
Mckay, P
Minami, Y
Mocikova, H
Morra, E
Munoz, J
Nagai, H
O'Connor, O
Opat, S
Pettengell, R
Pezzutto, A
Pfreundschuh, M
Pluta, A
Porcu, P
Quach, H
Rambaldi, A
Renwick, W
Reyes, R
Izquierdo, A
Ruan, J
Rusconi, C
Salles, G
Santoro, A
Sarriera, J
Savage, K
Shibayama, H
Suh, C
Sureda, A
Tanimoto, M
Taniwaki, M
Tilly, H
Trneny, M
Trumper, L
Tsukamoto, N
Vitolo, U
Walewski, J
Weidmann, E
Wilhelm, M
Witzens-Harig, M
Yacoub, A
Yamamoto, K
Yoon, S
Yun, H
Zain, J
Zinzan, P
Affiliation
Description
Date
2019
Publisher
Collections
Keywords
Type
Article
Citation
Horwitz S, O'Connor OA, Pro B, Illidge T, Fanale M, Advani R, et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019 Jan 19;393(10168):229-40.